| pubmed-article:2128472 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2128472 | lifeskim:mentions | umls-concept:C0018081 | lld:lifeskim |
| pubmed-article:2128472 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:2128472 | lifeskim:mentions | umls-concept:C0030830 | lld:lifeskim |
| pubmed-article:2128472 | lifeskim:mentions | umls-concept:C0055015 | lld:lifeskim |
| pubmed-article:2128472 | lifeskim:mentions | umls-concept:C1579762 | lld:lifeskim |
| pubmed-article:2128472 | lifeskim:mentions | umls-concept:C0009491 | lld:lifeskim |
| pubmed-article:2128472 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:2128472 | pubmed:dateCreated | 1991-5-30 | lld:pubmed |
| pubmed-article:2128472 | pubmed:abstractText | A total of 311 patients presenting with uncomplicated gonorrhoea were entered into a comparative randomized open-label study and given single-dose treatment with either oral cefuroxime axetil (CAE) or intramuscular procaine penicillin (PP). Neisseria gonorrhoeae was eliminated from 129 (98%) of 131 evaluable patients treated with CAE and 127 (98%) of 129 evaluable patients treated with PP. None of the 4 treatment failures (3 male and 1 female) were caused by beta-lactamase-producing isolates. Both treatments were well tolerated with minor adverse events reported in 3 (2%) of CAE treated patients. We conclude that CAE is an effective, well tolerated treatment for uncomplicated gonorrhoea which has the convenience and acceptability of single-dose oral therapy. | lld:pubmed |
| pubmed-article:2128472 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2128472 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2128472 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2128472 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2128472 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2128472 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2128472 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2128472 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2128472 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:2128472 | pubmed:issn | 0956-4624 | lld:pubmed |
| pubmed-article:2128472 | pubmed:author | pubmed-author:PatetJJ | lld:pubmed |
| pubmed-article:2128472 | pubmed:author | pubmed-author:SpencerR CRC | lld:pubmed |
| pubmed-article:2128472 | pubmed:author | pubmed-author:SmithT KTK | lld:pubmed |
| pubmed-article:2128472 | pubmed:author | pubmed-author:KinghornG RGR | lld:pubmed |
| pubmed-article:2128472 | pubmed:author | pubmed-author:RobinsonA JAJ | lld:pubmed |
| pubmed-article:2128472 | pubmed:author | pubmed-author:WoolleyP DPD | lld:pubmed |
| pubmed-article:2128472 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2128472 | pubmed:volume | 1 | lld:pubmed |
| pubmed-article:2128472 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2128472 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2128472 | pubmed:pagination | 285-7 | lld:pubmed |
| pubmed-article:2128472 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:meshHeading | pubmed-meshheading:2128472-... | lld:pubmed |
| pubmed-article:2128472 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2128472 | pubmed:articleTitle | Comparative study of cefuroxime axetil and procaine penicillin in the treatment of uncomplicated gonorrhoea. | lld:pubmed |
| pubmed-article:2128472 | pubmed:affiliation | Department of Genitourinary Medicine, Royal Hallamshire Hospital, Sheffield, UK. | lld:pubmed |
| pubmed-article:2128472 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2128472 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:2128472 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2128472 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:2128472 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
